RLX Technology Inc vs Twist Bioscience Corp — how do they compare? RLX Technology Inc trades at $1.98 (market cap $2.42B), while Twist Bioscience Corp trades at $123 (market cap $7.72B). The key difference: Twist Bioscience Corp is far larger — about 3.2× RLX Technology Inc's market cap, and RLX Technology Inc pays a 5.05% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| RLX | TWST | |
|---|---|---|
Market Cap | $2.42B | $7.72B |
Sector | Technology | Health |
52-Week High | $2.73 | $124.88 |
52-Week Low | $1.79 | $24.16 |
Enterprise Value | $1.04B | $7.65B |
Dividend Yield | 5.05% | — |
Trailing returns across standard periods
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →